Navigation Links
Study a step toward disease-resistant crops, sustainability
Date:11/12/2008

WEST LAFAYETTE, Ind. - A five-year study that could help increase disease resistance, stress tolerance and plant yields is under way at Purdue University.

The $4 million project uses a new technique called "mutant-assisted gene identification and characterization," or MAGIC, to identify potentially useful gene combinations in crop species.

"If we can understand these genes better, we could engineer plants to be immune to most diseases," said principal investigator Guri Johal, an associate professor of botany and plant pathology.

First using the corn genome, the method will add to the collection of useful alleles, or pairs of genes, that create certain traits. This will improve crop gene diversity, a quality that dwindles as crops are bred. Since natural selection has preserved such alleles, they likely confer a selective advantage that increases the ability of plants to survive, Johal said.

The MAGIC technique is described in a review article published this month in the journal Crop Science.

Maize contains more genetic diversity than any other model organism, making it an ideal plant for gene exploration, Johal said. In fact, two lines of corn are more different from one another than humans are from chimpanzees, said study co-author Cliff Weil, a professor of agronomy.

"Maize grows in places as different as northern Quebec, where it is cold and growing seasons are short, and the Mexican highlands, where it is very hot and dry," he said. "Natural adaptation to different environments has come by combining just the right sets of alleles in each variation."

MAGIC is a new tool needed to find genes, Johal said. Many recent research methods used to this end involve mutagenesis, with scientists deliberately causing a specific gene or genes to malfunction in order to determine the gene's impact on the plant.

"Mutagenesis has worked well, but we are reaching a period of diminishing returns,"
'/>"/>

Contact: Beth Forbes
forbes@purdue.edu
765-494-2722
Purdue University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Einstein researchers develop a new way to study how breast cancer spreads
2. UNC study: Text messaging may help children fight off obesity
3. SNPs affect folate metabolism in study of Puerto-Rican adults
4. Proteomics study yields clues as to how tuberculosis might be thwarting the immune system
5. Seasonal affective disorder may be linked to genetic mutation, study suggests
6. Sibling study could lead to better treatments for inherited form of colon cancer
7. Nature study demonstrates that bacterial clotting depends on clustering
8. Study sheds light on genetic differences that cause a childhood eye disease
9. Grapes may aid a bunch of heart risk factors, animal study finds
10. Study confirms amphibians ability to predict changes in biodiversity
11. Study rules out inbreeding as cause of amphibian deformities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... killers to prevent and treat HIV infection has been ... these molecules can arouse as they get rid of ... the Weizmann Institute and the National Institutes of Health ... molecules interferons around the time of infection ... disease. Their research appeared in Nature . ...
(Date:7/28/2014)... RENO Norwegian explorer Roald Amundsen became the first ... 1911. More than 100 years later, an international team ... Research Institute (DRI) have proven that air pollution from ... 16 ice cores collected from widely spaced locations around ... created the most accurate and precise reconstruction to date ...
(Date:7/27/2014)... Scientists have discovered a new species of mayfly in the ... of India. In fact, this is the first time that ... been collected in peninsular India. , The new species, called ... T. Soldan for his substantial contribution to the understanding of ... authors of a study that describes the new mayfly in ...
Breaking Biology News(10 mins):Interfering with interferon 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... new gasoline. But where,s the nearest "gas" station ... vehicle? Will hydrogen stations be strategically convenientlocated on ... What marketing development obstacles need to be overcome if ... and gain widespread acceptance? According to an article ...
... the effect of nutrients on muscle maintenance in the hope ... we get old. The researchers, based at the School ... know what sort of exercise we can take and what ... of skeletal muscle with ageing. The team from the ...
... from Tel Aviv University, the saying may be more than ... have an ability to "see" colors and shapes with their ... of a new book, Advances in Information Optics and ... optical imaging technology that beats the limitations of today,s lens-based ...
Cached Biology News:The viability of hydrogen transportation markets: Chicken or egg? 2A stronger future for the elderly 2Seeing through the skin 2
(Date:7/24/2014)... 24, 2014  ECC West Africa, LLC (ECC) signed ... with University College Hospital (UCH) Ibadan Board of Management ... finance, design, construct, and operate and maintain a new, ... . Under the first of the 4-phase project, ECC ... funding applications. UCH Ibadan intends to finance and develop ...
(Date:7/24/2014)... computers have yet to materialise. Yet, scientists are ... such computers faster. One such approach relies on ... by applying an electric field. A new study ... coupled quantum dots (TQDs) with electrical impulses can ... example, should TQDs be used as quantum information ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... Culture Market 2014-2018" report to their offering.  ... culture is the in vitro growth of plant or ... studies, and biopharmaceutical production. Cell culture is a crucial ... instruments and cell culture consumables are necessary for the ...
(Date:7/24/2014)... July 24, 2014 SRI International has been ... National Institute of Allergy and Infectious Diseases (NIAID), part ... development of potential therapies for HIV infection and AIDS. ... HIV and AIDS and the complications and opportunistic infections ... preventing sexual transmission of HIV. According ...
Breaking Biology Technology:ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3
... Health Robotics today announced,audited results for FY2008 ending ... orders, revenue, earnings and cash flow. , ... million, a 161% increase year-over-year as,the company began ... indirect,sales-channel franchise fee model, recurring revenue recognition, zero ...
... MESA, Calif., April 14 Oxygen Biotherapeutics, ... it has reached a development and commercial ... One(R) Global Pharmaceutical Services business unit to ... perfluorocarbon (PFC) therapeutic oxygen carrier. Oxycyte will ...
... April 14 BioVex Inc, a company developing ... and infectious disease, announced today that its OPTiM (OncoVEX Pivotal ... previously treated patients with Stage III and Stage IV melanoma ... U.S. with sites in the United Kingdom, Germany and Australia ...
Cached Biology Technology:Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 2Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 3Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 4Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 5Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs 2BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 2BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 3BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 4